Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Commercialization

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Feb 14, 2020 3:15am

123 Views

Post# 30689496

RE:RE:RE:Commercialization

“half a bill to get $5.00” means revenue of 50 Mio which can be achieved by getting a market share of around 1 % of the Veterinary Diagnostics 2025 (probably close the same in 2020) – so Nicks $ 20.00 is about 5 % market share of the Veterinary Diagnostics. If they can get the EUA or FDA approval by mid-year than they can also penetrate the Clinical Diagnostics which is more than twice the size of the Veterinary Diagnostics with a similar margin.
But this is all pending a successful commercialization - keep finger crossed they go to market in 2020

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario